+987.9%
MRNA vs EPAM
-15.2%
+1,003.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EPAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -0.6% | +13.7% | +13.4% |
| 7D | +20.6% | +0.8% | +19.8% | +19.6% |
| 30D | +27.1% | +24.9% | +2.2% | +9.8% |
| 3M | +353.4% | +22.6% | +330.8% | +278.5% |
| 6M | +446.3% | +24.2% | +422.1% | +354.8% |
| YTD | +776.2% | -33.0% | +809.1% | +741.2% |
| 1Y | +987.9% | -13.3% | +1,001.2% | +822.6% |
| All | +987.9% | -15.2% | +1,003.1% | +822.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EPAM.
Daily Out/Under-Performance
Portfolio return minus EPAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling